Atelerix Expands Hydrogel Cell Preservation Technology Through Middle East Partnership and New Organoid Solution
Key Insights
Atelerix (search) established a strategic partnership with JH Health Ltd (search) to bring its hydrogel-based cell preservation technology to the Middle East market with exclusive distribution rights.
The company launched STORganoid (search)™, an ambient-temperature preservation solution that enables storage and shipment of organoids and spheroids without compromising viability.
Atelerix (search)'s proprietary hydrogel technology eliminates the need for costly cold chain logistics by enabling biological samples to be stored at room temperature for up to two weeks.
Atelerix (search), a biotech company developing hydrogel encapsulation technology (search) for cell preservation, has announced two significant developments that expand its commercial reach and product portfolio. The company established a strategic partnership with Saudi Arabian firm JH Health Ltd (search) for Middle East distribution and launched STORganoid (search)™, a specialized preservation solution for complex 3D cell models.
Strategic Partnership Brings Technology to Middle East
The partnership with JH Health grants the Saudi Arabian company exclusive rights to use and distribute Atelerix (search)'s hydrogel-based cell and tissue preservation solutions throughout the Middle East region. This agreement represents a key component of Atelerix's global expansion strategy, which has previously established partnerships in China, Europe, and Africa.
"By partnering with JH Health, we gain access to the deep market expertise and local support needed to establish our operations in the Middle East," said Alastair Carrington, CEO of Atelerix (search). "Their strategic investment will enable us to build out our local manufacturing capabilities, ensuring we are equipped to deliver the future of biological transport logistics and meet the needs of the rapidly growing life science market in the region."
The collaboration will focus primarily on enabling stable transport of patient-derived biological samples for clinical diagnostics and research applications, including development of a new biobank within the region. JH Health will provide financial support and strategic expertise for Atelerix (search)'s operational scale-up, including local high-volume manufacturing capabilities and opportunities for new research partnerships.
Mohammed Al Jumah, CEO of JH Health, emphasized the partnership's potential impact: "By combining Atelerix (search)'s pioneering solutions with our regional expertise, this collaboration enhances access to advanced tools that support biomedical research, accelerate scientific discovery, and strengthen clinical development across the region, ultimately improving healthcare outcomes."
STORganoid™ Addresses 3D Cell Model Preservation Challenges
Atelerix (search) also announced the launch of STORganoid (search)™, an ambient-temperature preservation solution specifically designed for organoids and spheroids. The product addresses a significant barrier in the adoption of New Approach Methodologies (NAMs), where reliable transport and accessibility of human-relevant 3D cell models have been limited by their fragility and sensitivity to temperature fluctuations.
Traditional cryopreservation and hypothermic approaches can alter the structural and functional integrity of these complex systems, restricting their use to specialist laboratories and limiting broader adoption across global research teams. STORganoid (search)™ leverages Atelerix (search)'s proprietary hydrogel technology to enable storage at ambient temperatures in an assay-ready format, eliminating complex and time-consuming culture procedures.
"STORganoid (search) addresses one of the key barriers to broader adoption of these highly predictive cell-based models by freeing them from the constraints of specialized laboratory environments and lengthy culture protocols," said Steve Swioklo, CSO and Co-Founder of Atelerix (search). "We are proud to be contributing to the harmonization and accessibility of new approach methodologies (NAMs), helping to bring cutting-edge science closer to real-world application."
Hydrogel Technology Eliminates Cold Chain Requirements
Atelerix (search)'s proprietary hydrogel technology enables stable long-term storage and transport of sensitive biological samples by physically encapsulating cells and tissues in a soft hydrogel matrix that stabilizes membrane integrity. This approach allows samples to be stored at ambient temperature for up to two weeks, eliminating the need for costly cold chain logistics and preventing the loss of sample viability associated with cryopreservation.
The technology supports applications across drug discovery, disease modeling, and personalized medicine, while enabling new partnerships and more efficient global distribution. STORganoid (search)™ represents a scalable solution aligned with the growing organoid and cell therapy markets, expanding Atelerix (search)'s portfolio of fresh biosample storage products.